echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > [hot spot] GPO in Shenzhen is advancing into Nanning, and drug prices in Guangxi are afraid of fragmentation!

    [hot spot] GPO in Shenzhen is advancing into Nanning, and drug prices in Guangxi are afraid of fragmentation!

    • Last Update: 2019-04-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On April 12, Jilin issued the draft for comments on regional joint procurement, citing the new mode and practice of Guangdong Province, especially Shenzhen Pharmaceutical Group, and combining with the actual implementation of public hospitals in Jilin to carry out the pilot of drug cross regional alliance procurement Recently, a draft for comments on cross regional drug joint procurement issued by Nanning health and Health Commission (see the figure below) was circulated in the industry, which was promoted in Guangxi If Nanning and Shenzhen GPO carry out regional joint procurement, Guangxi drug prices are expected to present one region and two platforms (autonomous region platform + GPO platform), and price fragmentation is inevitable As the front position of reform and opening up, Guangdong has been in the first camp to try first and dare to taste fresh, from the first "sunshine purchase" to the radical version of "drug exchange mode" Guangxi, as a close neighbor of Guangdong, has always been gentle in the field of drug purchase According to the relevant national policies, the centralized drug purchase carried out in 2015 has achieved the direct negotiation of medical institutions in the field of direct online varieties, but it has not shown the fragmentation of drug prices However, in 2019, Shenzhen GPO and Wuzhou officially signed a regional procurement alliance, and the first batch of varieties (438 varieties + 25 anticancer drugs) officially launched on February 20 From the list of the first batch of distributors released on February 16, it can be seen that, first, there are only 30 distributors in a small number, second, the gold content is not high, and Guangxi's local large-scale businesses are not among them In order to ensure timely delivery, Shenzhen GPO forwarded the notice on opening up supplementary registration work for distribution enterprises in Wuzhou on February 20, which extended the delivery time If Nanning and Shenzhen GPO join hands formally this time, it means that low-cost transmission will officially enter Guangxi According to the "opinion draft" circulated this time, Nanning will dispatch experts to set up the procurement catalogue The autonomous region platform and GPO platform will interact well and complement each other's advantages After all, the "base number" of medical institutions in Nanning is so large, and the relative directionality of pharmaceutical enterprises is more single Drugs are sold by medical institutions Where the medical institutions go directly determines the choice platform of pharmaceutical enterprises Because once a medical institution chooses a platform, it's not feasible for pharmaceutical companies to sign orders from B platform Of course, there is another transition method If the same medical institution can choose either a or B, it will inevitably cause the dispersion of order quantity and price Therefore, for pharmaceutical companies, the combination of orders and prices, but is the best choice According to the above logic, if different medical institutions choose different platforms according to stages or cycles, for drug supply enterprises, there will be differences between the prices of the same product specification on platform a and platform B At present, the autonomous region level procurement platform and GPO platform, whether in terms of trading methods or bidding and bargaining trading rules, will definitely have different differences Only in this way can we form a price stagger, and truly encourage the two platforms to form an orderly and benign competition situation In order to form orderly and benign competition, at present, the tone of all parts of the country is very unified and simple: price reduction For pharmaceutical companies, the challenge is just as arduous and tedious That is to say, Nanning's "GPO" and the autonomous region level trading platform are expected to become a powerful starting point for the province to "reduce the false high price of drugs and eliminate the use of drugs to support medicine" On the other hand, it also reflects that under the market mechanism, the biggest role of the government at present is to guarantee the fair, open and fair competition environment of the market and to form a benign development atmosphere of the pharmaceutical market But what I can't understand is that if the trend of fragmentation of procurement continues, it will become a reality for large and small cities in Guangxi to carry out drug group procurement Then, a fixed quantity of Guangxi Province is divided into several small pieces, and then the quantity is exchanged for the price Then, the drug prices of various cities in Guangxi will really become a new depression compared with the low price What do you think? Welcome to discuss in the message area ~ statement: this point of view only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.